Safety and Tolerability of NNC0141-0000-0100 in Subjects With Rheumatoid Arthritis

NCT01370902 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation
Rheumatoid Arthritis

Interventions

DRUG: NNC 0141-0000-0100
DRUG: placebo
DRUG: NNC 0141-0000-0100
DRUG: placebo
DRUG: NNC 0141-0000-0100
DRUG: placebo

Sponsor

Innate Pharma